JACOBS LEVY EQUITY MANAGEMENT, INC - ENANTA PHARMACEUTICALS INC ownership

ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 132 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.88 and the average weighting 0.0%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of ENANTA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$3,860,922
-48.1%
345,651
-0.5%
0.02%
-46.5%
Q2 2023$7,433,247
-46.9%
347,348
+0.3%
0.04%
-50.0%
Q1 2023$14,010,640
-13.7%
346,455
-0.7%
0.09%
-21.8%
Q4 2022$16,238,179
-11.1%
349,058
-0.9%
0.11%
-23.6%
Q3 2022$18,274,000
+29.9%
352,303
+18.4%
0.14%
+32.1%
Q2 2022$14,064,000
-29.0%
297,532
+6.9%
0.11%
-18.0%
Q1 2022$19,818,000
-1.9%
278,423
+3.1%
0.13%
-1.5%
Q4 2021$20,200,000
+40.1%
270,130
+6.4%
0.14%
+39.2%
Q3 2021$14,419,000
+26.2%
253,814
-2.2%
0.10%
+26.0%
Q2 2021$11,423,000
-4.4%
259,553
+7.1%
0.08%
-16.3%
Q1 2021$11,948,000
+14.3%
242,257
-2.4%
0.09%0.0%
Q4 2020$10,454,000
-10.8%
248,320
-3.0%
0.09%
-24.6%
Q3 2020$11,723,000
-11.7%
256,064
-3.1%
0.12%
-15.3%
Q2 2020$13,269,000
+51.1%
264,261
+54.7%
0.14%
+27.4%
Q1 2020$8,783,000
+65.7%
170,785
+99.1%
0.11%
+117.3%
Q4 2019$5,300,000
+23.6%
85,787
+20.2%
0.05%
-1.9%
Q3 2019$4,288,000
-12.4%
71,374
+23.1%
0.05%
-22.1%
Q2 2019$4,894,000
+113.5%
58,004
+116.3%
0.07%
+106.1%
Q3 2018$2,292,000
+56.0%
26,822
+111.6%
0.03%
+43.5%
Q2 2018$1,469,000
-36.8%
12,677
-55.9%
0.02%
-41.0%
Q1 2018$2,324,000
+34.7%
28,720
-2.3%
0.04%
+30.0%
Q4 2017$1,725,000
+319.7%
29,400
+110.1%
0.03%
+233.3%
Q1 2016$411,00013,9920.01%
Other shareholders
ENANTA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 858,811$36,156,00010.56%
Fairmount Funds Management LLC 150,433$6,333,0002.26%
ARMISTICE CAPITAL, LLC 1,356,000$57,088,0001.94%
FARALLON CAPITAL MANAGEMENT LLC 1,775,000$74,728,0000.45%
Virtus ETF Advisers LLC 14,321$603,0000.25%
Granahan Investment Management 231,071$9,728,0000.22%
JACOBS LEVY EQUITY MANAGEMENT, INC 248,320$10,454,0000.09%
ACADIAN ASSET MANAGEMENT LLC 467,514$19,684,0000.08%
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. 126$5,0000.08%
AIGEN INVESTMENT MANAGEMENT, LP 12,854$541,0000.07%
View complete list of ENANTA PHARMACEUTICALS INC shareholders